Literature DB >> 20222294

Management of premature ventricular complexes.

Albert K Chan1, Mary L Dohrmann.   

Abstract

Premature ventricular contractions (PVCs) are frequently encountered, and management is determined by symptoms, precipitating factors, and the presence of underlying cardiac disease. No treatment is indicated in patients with asymptomatic PVCs in absence of cardiac disease. Symptomatic patients without cardiac disease may be managed by identifying and correcting reversible causes. In patients with cardiac disease, management includes treating the underlying cardiac disease to improve both symptoms and prognosis.

Entities:  

Mesh：

Year:  2010        PMID： 20222294      PMCID： PMC6192796     

Source DB:  PubMed          Journal:  Mo Med        ISSN： 0026-6620


  21 in total

Review 1.  Ventricular arrhythmias in patients with mitral valve prolapse.

Authors:  S F Schaal
Journal:  Cardiovasc Clin       Date:  1992

2.  ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons.

Authors:  Andrew E Epstein; John P DiMarco; Kenneth A Ellenbogen; N A Mark Estes; Roger A Freedman; Leonard S Gettes; A Marc Gillinov; Gabriel Gregoratos; Stephen C Hammill; David L Hayes; Mark A Hlatky; L Kristin Newby; Richard L Page; Mark H Schoenfeld; Michael J Silka; Lynne Warner Stevenson; Michael O Sweeney; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffrey L Anderson; Christopher E Buller; Mark A Creager; Steven M Ettinger; David P Faxon; Jonathan L Halperin; Loren F Hiratzka; Sharon A Hunt; Harlan M Krumholz; Frederick G Kushner; Bruce W Lytle; Rick A Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel; Lynn G Tarkington; Clyde W Yancy
Journal:  Circulation       Date:  2008-05-15       Impact factor: 29.690

3.  Arrhythmias documented by 24-hour continuous ambulatory electrocardiographic monitoring in young women without apparent heart disease.

Authors:  P A Sobotka; J H Mayer; R A Bauernfeind; C Kanakis; K M Rosen
Journal:  Am Heart J       Date:  1981-06       Impact factor: 4.749

4.  ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.

Authors:  Douglas P Zipes; A John Camm; Martin Borggrefe; Alfred E Buxton; Bernard Chaitman; Martin Fromer; Gabriel Gregoratos; George Klein; Arthur J Moss; Robert J Myerburg; Silvia G Priori; Miguel A Quinones; Dan M Roden; Michael J Silka; Cynthia Tracy; Jean-Jacques Blanc; Andrzej Budaj; Veronica Dean; Jaap W Deckers; Catherine Despres; Kenneth Dickstein; John Lekakis; Keith McGregor; Marco Metra; Joao Morais; Ady Osterspey; Juan Luis Tamargo; José Luis Zamorano; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Elliott M Antman; Jeffrey L Anderson; Sharon A Hunt; Jonathan L Halperin; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
Journal:  Eur Heart J       Date:  2006-09       Impact factor: 29.983

5.  Prevalence of premature ventricular contractions in a population of African American and white men and women: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Ross J Simpson; Wayne E Cascio; Pamela J Schreiner; Richard S Crow; Pentti M Rautaharju; Gerardo Heiss
Journal:  Am Heart J       Date:  2002-03       Impact factor: 4.749

6.  Frequent ventricular ectopy after exercise as a predictor of death.

Authors:  Joseph P Frolkis; Claire E Pothier; Eugene H Blackstone; Michael S Lauer
Journal:  N Engl J Med       Date:  2003-02-27       Impact factor: 91.245

7.  Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators.

Authors:  J A Cairns; S J Connolly; R Roberts; M Gent
Journal:  Lancet       Date:  1997-03-08       Impact factor: 79.321

8.  Prognostic implications of asymptomatic ventricular arrhythmias: the Framingham Heart Study.

Authors:  M Bikkina; M G Larson; D Levy
Journal:  Ann Intern Med       Date:  1992-12-15       Impact factor: 25.391

9.  Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial.

Authors:  D S Echt; P R Liebson; L B Mitchell; R W Peters; D Obias-Manno; A H Barker; D Arensberg; A Baker; L Friedman; H L Greene
Journal:  N Engl J Med       Date:  1991-03-21       Impact factor: 91.245

10.  Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure.

Authors:  S N Singh; R D Fletcher; S G Fisher; B N Singh; H D Lewis; P C Deedwania; B M Massie; C Colling; D Lazzeri
Journal:  N Engl J Med       Date:  1995-07-13       Impact factor: 91.245
View more
  1 in total

1.  Association of Longitudinal Changes in Cardiac Biomarkers With Atrial and Ventricular Arrhythmias (from the Atherosclerosis Risk in Communities [ARIC] Study).

Authors:  Parveen K Garg; Faye L Norby; Wendy Wang; Darshan Krishnappa; Elsayed Z Soliman; Pamela L Lutsey; Elizabeth Selvin; Christie M Ballantyne; Alvaro Alonso; Lin Y Chen
Journal:  Am J Cardiol       Date:  2021-08-28       Impact factor: 2.778
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.